Barts and The London School of Medicine and Dentistry, commonly known as Barts, is a medical and dental school in London, England. The school is part of Queen Mary University of London, a constituent college of the federal University of London, and a member of the United Hospitals.

During the past decade, Barts and the London School of Medicine conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Barts and the London School of Medicine" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "ApoPharma" with 2 trials sponsored, "Barts and the London School of Medicine and Dentistry" with 2 trials sponsored, "Cancer Research UK" with 2 trials sponsored and "Institute of Cancer Research, United Kingdom" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Barts and the London School of Medicine" #1 collaborator was "Barts and the London School of Medicine and Dentistry" with 1 trials as a collaborator, "BioNTech SE" with 1 trials as a collaborator, "Cancer Research UK" with 1 trials as a collaborator and "Gilead Sciences, Inc., GlaxoSmithKline plc, Seattle Genetics and Astellas" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Barts and the London School of Medicine" are "Bladder Cancer" (4 trials), "Breast Cancer" (3 trials), "Iron Overload" (2 trials), "Other Anemias" (2 trials) and "Precancerous Condition" (2 trials). Many other conditions were trialed in "Barts and the London School of Medicine" in a lesser frequency.

Most popular intervention types in "Barts and the London School of Medicine" are "Drug" (15 trials), "Other" (6 trials), "Procedure" (6 trials), "Biological" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "laboratory biomarker analysis" (3 trials), "Deferiprone" (2 trials), "adjuvant therapy" (2 trials) and "cervical Papanicolaou test" (2 trials). Other intervention names were less common.

The vast majority of trials in "Barts and the London School of Medicine" are 13 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Barts and the London School of Medicine". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Barts and the London School of Medicine, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Barts and the London School of Medicine, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".